Asker Healthcare (ASKER) - Total Liabilities
Based on the latest financial reports, Asker Healthcare (ASKER) has total liabilities worth Skr10.88 Billion SEK (≈ $1.17 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Asker Healthcare - Total Liabilities Trend (2021–2025)
This chart illustrates how Asker Healthcare's total liabilities have evolved over time, based on quarterly financial data. See ASKER working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Asker Healthcare Competitors by Total Liabilities
The table below lists competitors of Asker Healthcare ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
National HealthCare Corporation
NYSE MKT:NHC
|
USA | $427.48 Million |
|
ASPEN PHAR.UN.ADR /1 O.N.
F:LDZU
|
Germany | €46.96 Billion |
|
GQG PARTNERS CDI/1/1
F:6P1
|
Germany | €50.29 Million |
|
Enerflex Ltd.
NYSE:EFXT
|
USA | $1.58 Billion |
|
Kaiser Aluminum Corporation
NASDAQ:KALU
|
USA | $1.91 Billion |
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
USA | $57.43 Million |
|
Quick Intelligent Equipment Co Ltd
SHG:603203
|
China | CN¥752.93 Million |
|
TISCO Financial Group Public Company Limited
BK:TISCO
|
Thailand | ฿240.46 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down Asker Healthcare's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Asker Healthcare.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.59 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Asker Healthcare's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Asker Healthcare (2021–2025)
The table below shows the annual total liabilities of Asker Healthcare from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr10.19 Billion ≈ $1.10 Billion |
+5.93% |
| 2024-12-31 | Skr9.62 Billion ≈ $1.03 Billion |
+16.07% |
| 2023-12-31 | Skr8.29 Billion ≈ $891.60 Million |
+11.31% |
| 2022-12-31 | Skr7.44 Billion ≈ $800.99 Million |
+34.33% |
| 2021-12-31 | Skr5.54 Billion ≈ $596.30 Million |
-- |
About Asker Healthcare
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating roo… Read more